Results 131 to 140 of about 36,199 (325)

Temporal Trend in Selective Cyclooxygenase‐2 Inhibitors Sales in Brazilian Drugstores [PDF]

Pharmacoepidemiol Drug Saf
ABSTRACT Purpose To assess the trends in selective cyclooxygenase‐2 inhibitor anti‐inflammatory drugs (coxibs) sales in Brazil from 2014 to 2021. Methods A time trend analysis of coxibs sales in Brazil from January 2014 to December 2021 was conducted using the Brazilian National Controlled Products Management System.
Biase T, Silva M, Lopes L, Galvao T.
europepmc   +2 more sources

Pharmacokinetics and pharmacoepidemiology

International Journal of Pharmacy Practice, 1994
AbstractPharmacokinetic methodology should be included in pharmacoepidemiology and postmarketing ...
H. G. M. Leufkens, J. Zuidema
openaire   +2 more sources

The association between benzodiazepines and influenza-like illness-related pneumonia and mortality: a survival analysis using UK Primary Care data [PDF]

, 2016
Purpose: Bacterial superinfections, including pneumonia, are frequent complications of influenza-like illness (ILI). Clinical and laboratory evidence suggests that benzodiazepines and Z-drugs may influence susceptibility to infections and mortality.
Almirall, BNF, Charlson, Domingues-Junior, Dublin, Dublin, Dupouy, Ekström, Galdiero, Gleason, Hak, Iwata, Joya, Kripke, Laschi, Lim, Mortensen, Nakafero, Obiora, Pandharipande, Pandharipande, Peduzzi, Riker, Sanders, Sanders, Sanders, Sanders, Schneeweiss, Schneeweiss, Sluijs, Sundararajan, Vittinghoff, Webster, Weich, Woods   +34 more
core   +2 more sources

Prognostic Factors and Effect Modifiers in Patients With Relapse or Refractory Diffuse Large B‐Cell Lymphoma After Two Lines of Therapy: A Systematic Literature and Expert Clinical Review

European Journal of Haematology, EarlyView.
ABSTRACT Objectives The objective of this systematic literature review (SLR) combined with expert clinical review was to identify and rank prognostic factors and effect measure modifiers (EMMs) systematically and comprehensively in patients with relapsed or refractory (R/R) diffuse large B‐cell lymphoma (DLBCL) who initiate treatment after ≥ 2 prior ...
Bastian von Tresckow, Pau Abrisqueta, Irene Zamanillo, Ángel Serna Pareja, Yuting Kuang, Jennifer Uyei, Mohsin Shah, Laura Walsh, Eileen Thorley, Krystal Cantos, Emaan Rashidi, Christian Hampp, Jessica J. Jalbert, Alexi N. Archambault, Yingxin Xu, Shivani Aggarwal, Srikanth Ambati, Hesham Mohamed, Qiufei Ma, Ana Jiménez‐Ubieto   +19 more
wiley   +1 more source

Current awareness: Pharmacoepidemiology and drug safety [PDF]

, 2004

  +6 more sources

Effectiveness and safety of adjunctive cenobamate in people with focal‐onset epilepsy: Interim results after 24‐week observational period from the BLESS study

Epilepsia, EarlyView.
Abstract Objective Cenobamate is an antiseizure medication (ASM) with a dual mechanism of action that was recently approved for the treatment of focal seizures in adults. This analysis aimed to describe the outcomes at 12 and 24 weeks after starting cenobamate therapy in a real‐world setting.
Simona Lattanzi, Fedele Dono, Giuseppe d'Orsi, Alfredo D'Aniello, Mariangela Panebianco, Paolo Bonanni, Carlo Di Bonaventura, Elisa Montalenti, Antonio Gambardella, Federica Ranzato, Giada Pauletto, Elena Tartara, Angela La Neve, Francesca Bisulli, Giampaolo Vatti, Patrizia Pulitano, Claudio Liguori, Giovanni Assenza, Alfonso Giordano, Pietro Pignatta, Vincenzo Belcastro, Michela Cecconi, Simone Beretta, Chiara Pizzanelli, Marianna Pezzella, Massimo Gangitano, Maurizio Elia, Rosaria Renna, Catello Vollono, Angelo Pascarella, Luciana Tramacere, Giovanni De Maria, Daniela Audenino, Maria Pia Pasolini, Loretta Giuliano, Rosita Galli, Gionata Strigaro, Monica Puligheddu, Angelo Labate, Pietro Penza, Stefano Quadri, David Stokelj, Giovanni Boero, Elisa Fallica, Monica Santo Sabato, Giovanni Falcicchio, Nicoletta Foschi, Michela Procaccini, Valentina Villano, Gabriele Camattari, Fabiano Mele, Barbara Roncari, Giancarlo Di Gennaro, the BLESS Study Group   +53 more
wiley   +1 more source

Databases in the Asia-Pacific Region: The Potential for a Distributed Network Approach [PDF]

, 2015
Background: This study describes the availability and characteristics of databases in Asian-Pacific countries and assesses the feasibility of a distributed network approach in the region.
Chaiyakunapruk, N, Chantelle, HN, Cheng, CL, Chien, HC, Chui, SLC, Dilokthornsakul, P, Hsieh, CY, Hsu, CY, Lai, ECC, Man, KCK   +9 more
core   +1 more source

Switching From Standard to Extended Half‐Life Coagulation Factor Replacement in Haemophilia: Clinical Outcomes and Costs of Care in Finland

Haemophilia, EarlyView.
ABSTRACT Introduction Real‐world data are needed to evaluate treatment implementation, outcomes and costs of care in haemophilia patients switching prophylaxis from standard half‐life (SHL) to extended half‐life (EHL) clotting factor concentrates (CFCs).
Mirkka Koivusalo, Timea Szanto, Tuomas Kovalainen, Aino Vesikansa, Outi Laine, Anu Partanen, Timo Siitonen, Marko Vesanen, Juha Mehtälä, Nina Sarnesto, Johanna Haapkylä, Anna‐Elina Lehtinen, Riitta Lassila   +12 more
wiley   +1 more source

Helping everyone do better: a call for validation studies of routinely recorded health data. [PDF]

, 2016
There has been a surge of availability and use for research of routinely collected electronic health data, such as electronic health records, health administrative data, and disease registries. Symptomatic of this surge, in 2012, Pharmacoepidemiology and
Benchimol, Eric I, Ehrenstein, Vera, Jick, Susan S, Ludvigsson, Jonas F, Petersen, Irene, Smeeth, Liam, Sørensen, Henrik Toft   +6 more
core   +2 more sources

Epidemiology of Psoriasis in Poland: Prevalence, Incidence, and Mortality Rates

International Journal of Dermatology, EarlyView.
ABSTRACT Background Although the data on psoriasis epidemiology included in the Global Psoriasis Atlas (GPA) provide valuable information on psoriasis prevalence worldwide, the GPA database is still incomplete. Therefore, the aim of the study was to assess the prevalence, incidence, and mortality rates of psoriasis and its types in Poland based on the ...
Joanna Bartosińska, Jacek C. Szepietowski, Dorota Raczkiewicz, Christopher E. M. Griffiths, Darren M. Ashcroft, Alison K. Wright, Krzysztof Podwójcic, Jakub Turcza, Michał Maluchnik, Agnieszka Chłoń‐Domińczak, Dorota Krasowska   +10 more
wiley   +1 more source